Fidelity International
DGX icon

Fidelity International’s Quest Diagnostics DGX Stock Holding History

Fidelity International’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17M Buy
86,569
+55,598
+180% +$10.8M 0.01% 511
2025
Q4 		$5.37M Buy
30,971
+11,630
+60% +$2.12M ﹤0.01% 642
2025
Q3 		$3.69M Buy
+19,341
New +$3.43M ﹤0.01% 675
2024
Q4 		– Sell
-4,561
Closed -$708K – 930
2024
Q3 		$708K Buy
+4,561
New +$681K ﹤0.01% 750
2021
Q2 		– Sell
-25,540
Closed -$3.28M – 908
2021
Q1 		$3.28M Hold
25,540
– – ﹤0.01% 642
2020
Q4 		$3.04M Buy
25,540
+409
+2% +$49.9K ﹤0.01% 589
2020
Q3 		$2.88M Sell
25,131
-4
-0% -$473 ﹤0.01% 576
2020
Q2 		$2.86M Sell
25,135
-780,287
-97% -$82.8M ﹤0.01% 556
2020
Q1 		$64.7M Sell
805,422
-453,093
-36% -$46.9M 0.11% 191
2019
Q4 		$134M Buy
1,258,515
+84,615
+7% +$8.82M 0.19% 148
2019
Q3 		$126M Buy
1,173,900
+60,822
+5% +$6.24M 0.19% 141
2019
Q2 		$113M Buy
1,113,078
+876,724
+371% +$84.2M 0.17% 148
2019
Q1 		$21.3M Sell
236,354
-57,262
-20% -$4.96M 0.03% 354
2018
Q4 		$24.4M Sell
293,616
-23,840
-8% -$2.24M 0.04% 326
2018
Q3 		$34.3M Buy
317,456
+30,352
+11% +$3.33M 0.05% 314
2018
Q2 		$31.6M Buy
287,104
+120,674
+73% +$12.6M 0.05% 322
2018
Q1 		$16.7M Buy
+166,430
New +$17M 0.05% 290
2016
Q4 		– Sell
-352,328
Closed -$29.8M – 519
2016
Q3 		$29.8M Hold
352,328
– – 0.09% 191
2016
Q2 		$28.7M Buy
352,328
+87,899
+33% +$6.69M 0.09% 190
2016
Q1 		$18.9M Sell
264,429
-1,621
-0.6% -$109K 0.06% 251
2015
Q4 		$18.9M Sell
266,050
-149,691
-36% -$10.1M 0.06% 257
2015
Q3 		$25.6M Sell
415,741
-567,920
-58% -$39.7M 0.09% 208
2015
Q2 		$71.3M Sell
983,661
-958,624
-49% -$70.8M 0.23% 112
2015
Q1 		$149M Buy
1,942,285
+16,845
+0.9% +$1.21M 0.48% 62
2014
Q4 		$129M Sell
1,925,440
-901
-0% -$56.9K 0.45% 68
2014
Q3 		$117M Buy
+1,926,341
New +$119M 0.45% 63

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Fidelity International's DGX Position: Q1 2026 in Review

Fidelity International increased its Quest Diagnostics (DGX) stake by 180% in Q1 2026, buying an estimated $10.8M and bringing the position to 86,569 shares worth $17M. The position accounts for 0.01% of the portfolio, ranked #511.

Fidelity International first reported a position in DGX in Q3 2014 and has held it in 26 quarters since. The position peaked at $149M in Q1 2015. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Fidelity International held 86,569 shares of Quest Diagnostics worth $17M as of Q1 2026.
  • Fidelity International bought 55,598 Quest Diagnostics shares in Q1 2026, an estimated $10.8M.
  • Quest Diagnostics made up 0.01% of Fidelity International's portfolio in Q1 2026, its #511 holding.
  • Fidelity International first reported a position in Quest Diagnostics in Q3 2014 and has held it in 26 quarters since.
  • Fidelity International's Quest Diagnostics position peaked at $149M in Q1 2015.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.